Key Role of Connective Tissue Growth Factor (CTGF) in Familial Cardiomyopathy and Heart Failure

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Familial cardiomyopathies are an important cause of heart failure and sudden death. Understanding the precise mechanisms of how disease develops in cardiomyopathies is an important step for developing new therapeutic and prevention strategies. We plan to investigate the role of connective tissue growth factor (CTGF) , an important protein which causes scar formation in the heart, in cells, mice, and humans predisposed to developing heart disease.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $395,051.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Animal model | Biological markers | Cardiac failure | Cardiac hypertrophy and fibrosis | Cardiomyopathy | Genetics | Heart failure | Inherited disease